157 related articles for article (PubMed ID: 24038829)
1. Pregnancy after cancer: results from a prospective cohort study of cancer survivors.
Dillon KE; Sammel MD; Ginsberg JP; Lechtenberg L; Prewitt M; Gracia CR
Pediatr Blood Cancer; 2013 Dec; 60(12):2001-6. PubMed ID: 24038829
[TBL] [Abstract][Full Text] [Related]
2. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
3. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
4. Impact of cancer therapies on ovarian reserve.
Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
[TBL] [Abstract][Full Text] [Related]
5. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.
Cameron K; Sammel MD; Prewitt M; Gracia C
J Clin Endocrinol Metab; 2019 May; 104(5):1813-1822. PubMed ID: 30566616
[TBL] [Abstract][Full Text] [Related]
6. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
7. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
[TBL] [Abstract][Full Text] [Related]
9. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
11. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.
Lutchman Singh K; Davies M; Chatterjee R
Hum Reprod Update; 2005; 11(1):69-89. PubMed ID: 15569700
[TBL] [Abstract][Full Text] [Related]
12. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
13. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
14. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
15. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
[TBL] [Abstract][Full Text] [Related]
16. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
17. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
[TBL] [Abstract][Full Text] [Related]
18. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in female cancer survivors: is it related to ovarian reserve?
Kondapalli LA; Dillon KE; Sammel MD; Ray A; Prewitt M; Ginsberg JP; Gracia CR
Qual Life Res; 2014 Mar; 23(2):585-92. PubMed ID: 23881516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]